Parian Global Management’s AngioDynamics ANGO Stock Holding History

Parian Global Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-82,500	Closed	-$2.27M	–	13
2021 Q4	$2.27M	Sell	82,500 -39,162	-32%	-$1.08M	1.83%	17
2021 Q3	$3.16M	Sell	121,662 -149,616	-55%	-$4M	2.2%	15
2021 Q2	$7.36M	Buy	271,278 +139,833	+106%	+$3.41M	3.16%	10
2021 Q1	$3.08M	Buy	+131,445	New	+$2.66M	1.41%	16
2020 Q4	–	Sell	-347,000	Closed	-$4.18M	–	55
2020 Q3	$4.18M	Buy	+347,000	New	+$3.29M	1.33%	26

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Parian Global Management's ANGO Position: Q1 2022 in Review

Parian Global Management sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 82,500 shares — an estimated $2.27M sold.

Parian Global Management first reported a position in ANGO in Q3 2020 and held it in 5 quarters. The position peaked at $7.36M in Q2 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

Parian Global Management reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
Parian Global Management sold 82,500 AngioDynamics shares in Q1 2022, an estimated $2.27M.
Parian Global Management first reported a position in AngioDynamics in Q3 2020 and held it in 5 quarters.
Parian Global Management's AngioDynamics position peaked at $7.36M in Q2 2021.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Parian Global Management's 13F filing for Q1 2022, filed 16 May 2022.